Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Rachel Pullen, Marc Miravitlles, Anita Sharma, Dave Singh, Fernando Martinez, John R Hurst, Luis Alves, Mark Dransfield, Rongchang Chen, Shigeo Muro, Tonya Winders, Christopher Blango, Hana Muellerova, Frank Trudo, Paul Dorinsky, Marianna Alacqua, Tamsin Morris, Victoria Carter, Amy Couper, Rupert Jones, Konstantinos Kostikas, Ruth Murray & David B Price. (2021) CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2301-2322.
Read now
Read now
Jaco Voorham, Simonetta Baldi, Luigi Santoro, Marjan Kerkhof, Marco Contoli, Leonardo M Fabbri, Huib A M Kerstjens, Jose Luis López-Campos, Nicolas Roche, Dave Singh, Claus F Vogelmeier & David B Price. (2020) Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD: A Historical Real-World Non-Inferiority Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2739-2750.
Read now
Read now
Erminia Ridolo, Irene Pellicelli, Bruna Gritti & Cristoforo Incorvaia. (2019) Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide. Patient Preference and Adherence 13, pages 145-150.
Read now
Read now
Timothy E Albertson, Willis S Bowman, Richart W Harper, Regina M Godbout & Susan Murin. (2019) Evidence-based review of data on the combination inhaler umeclidinium/vilanterol in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1251-1265.
Read now
Read now
Paola Rogliani, Luigino Calzetta, Fulvio Braido, Mario Cazzola, Enrico Clini, Girolamo Pelaia, Andrea Rossi, Nicola Scichilone & Fabiano Di Marco. (2018) LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3115-3130.
Read now
Read now
Articles from other publishers (17)
Ching-Fu Weng, Chien-Chih Wu, Mei-Hsuan Wu & Fang-Ju Lin. (2023) Comparison of Clinical Outcomes Among Different Fixed-Dose Combinations of Long-Acting Muscarinic Antagonists and Long-Acting β2-Agonists in Patients With COPD. Chest 163:4, pages 799-814.
Crossref
Crossref
Samrad Mehrabi, Alireza Salehi, Hossein Molavi Vardanjani, Ali kooshki & Fereshteh Mehrabi. (2023) Validity and Reliability of the Persian Version of the St. George Respiratory Questionnaire for COPD. Journal of Advances in Medical and Biomedical Research 31:144, pages 93-99.
Crossref
Crossref
Afisi S. Ismaila, Katrin Haeussler, Alexandrosz Czira, Vanita Tongbram, Mia Malmenäs, Jatin Agarwal, Maria Nassim, Marija Živković-Gojović, Yunrong Shen, Xinzhe Dong, Maria Duarte, Chris Compton, Claus F. Vogelmeier & David M. G. Halpin. (2022) Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis. Advances in Therapy 39:11, pages 4961-5010.
Crossref
Crossref
A. I. Sinopalnikov. (2021) Pharmacotherapeutic strategy for COPD patients: focus on dual bronchodilators. Meditsinskiy sovet = Medical Council:16, pages 38-44.
Crossref
Crossref
Shih-Lung Cheng. (2021) Comparison of Effectiveness Using Different Dual Bronchodilator Agents in Chronic Obstructive Pulmonary Disease Treatment. Journal of Clinical Medicine 10:12, pages 2649.
Crossref
Crossref
María Montes de Oca, Maria Victorina López Varela, Agustín Acuña, Eduardo Schiavi, Alejandro Casas, Antonio Tokumoto, Carlos A. Torres Duque, Alejandra Ramírez-Venegas, Gabriel García, Aquiles Camelier, Miguel Bergna, Mark Cohen, Efraín Sanchez-Angarita, Santiago Guzmán, Karen Czischke, Manuel Barros & Alejandra Rey. (2020) Incorporando nuevas evidencias sobre medicamentos inhalados en la EPOC. Asociación Latinoamericana de Tórax (ALAT) 2019. Archivos de Bronconeumología 56:2, pages 106-113.
Crossref
Crossref
Maria Montes de Oca, Maria Victorina López Varela, Agustín Acuña, Eduardo Schiavi, Alejandro Casas, Antonio Tokumoto, Carlos A. Torres Duque, Alejandra Ramírez-Venegas, Gabriel García, Aquiles Camelier, Miguel Bergna, Mark Cohen, Efraín Sanchez-Angarita, Santiago Guzmán, Karen Czischke, Manuel Barros & Alejandra Rey. (2020) Incorporating new evidence on inhaled medications in COPD. The latin American chest association (ALAT) 2019. Archivos de Bronconeumología (English Edition) 56:2, pages 106-113.
Crossref
Crossref
Mónica Helena Correia Pereira, João Miguel Bettencourt Sena Carvalho, Paula Maria Gonçalves Pinto & Maria do Carmo Oliveira Cordeiro. 2020. Noninvasive Ventilation Technologies and Healthcare for Geriatric Patients. Noninvasive Ventilation Technologies and Healthcare for Geriatric Patients
180
192
.
David M. Mannino. (2019) Biomarkers for chronic obstructive pulmonary disease diagnosis and progression. Current Opinion in Pulmonary Medicine 25:2, pages 144-149.
Crossref
Crossref
Eric Derom, Guy G. Brusselle & Guy F. Joos. (2019) The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects. Therapeutic Advances in Respiratory Disease 13, pages 175346661984342.
Crossref
Crossref
A. I. Sinopalnikov. (2018) Fixed-dose combinations of bronchodilators in the treatment of patients with COPD: problem of choice. Medical Council:15, pages 96-100.
Crossref
Crossref
Jose Luis Lopez-Campos, Laura Carrasco Hernández, Xavier Muñoz, Víctor Bustamante & Esther Barreiro. (2018) Current controversies in the stepping up and stepping down of inhaled therapies for COPD at the patient level. Respirology 23:9, pages 818-827.
Crossref
Crossref
Antonio Anzueto & Marc Miravitlles. (2018) Considerations for the Correct Diagnosis of COPD and Its Management With Bronchodilators. Chest 154:2, pages 242-248.
Crossref
Crossref
Mario Cazzola & Paola Rogliani. (2017) Comparative effectiveness of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary disease. Journal of Comparative Effectiveness Research 6:7, pages 627-636.
Crossref
Crossref
Marc Miravitlles, Juan José Soler-Cataluña, Myriam Calle, Jesús Molina, Pere Almagro, José Antonio Quintano, Juan Antonio Trigueros, Borja G. Cosío, Ciro Casanova, Juan Antonio Riesco, Pere Simonet, David Rigau, Joan B. Soriano & Julio Ancochea. (2017) Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable. Archivos de Bronconeumología 53:6, pages 324-335.
Crossref
Crossref
Marc Miravitlles, Juan José Soler-Cataluña, Myriam Calle, Jesús Molina, Pere Almagro, José Antonio Quintano, Juan Antonio Trigueros, Borja G. Cosío, Ciro Casanova, Juan Antonio Riesco, Pere Simonet, David Rigau, Joan B. Soriano & Julio Ancochea. (2017) Spanish COPD Guidelines (GesEPOC) 2017. Pharmacological Treatment of Stable Chronic Obstructive Pulmonary Disease. Archivos de Bronconeumología (English Edition) 53:6, pages 324-335.
Crossref
Crossref
. (2017) Tratamiento de la EPOC Estable. Archivos de Bronconeumología 53, pages 23-33.
Crossref
Crossref